# Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

> **NCT06488001** · PHASE2 · RECRUITING · sponsor: **United States Naval Medical Center, Portsmouth** · enrollment: 132 (estimated)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** pantoprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06488001
- **Lead sponsor:** United States Naval Medical Center, Portsmouth
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-26
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06488001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06488001, "Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06488001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*